Actively Targeted Low-Dose Camptothecin as a Safe, Long-Acting, Disease-Modifying Nanomedicine for Rheumatoid Arthritis

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery

(2009) Oleh Taratula et al.   JOURNAL OF CONTROLLED RELEASE

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

(2009) Andrea Rubbert-Roth et al.   ARTHRITIS RESEARCH & THERAPY

Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

(2008) Mario Delgado et al.   ARTHRITIS AND RHEUMATISM

A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma

(2008) L. C. Scott et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Topoisomerase inhibitors as anti-arthritic agents

(2008) J. K. Jackson et al.   INFLAMMATION RESEARCH

Intracellular delivery of VIP-grafted sterically stabilized phospholipid mixed nanomicelles in human breast cancer cells

(2007) Israel Rubinstein et al.   CHEMICO-BIOLOGICAL INTERACTIONS